Mitsushiro Nakatomi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mitsushiro Nakatomi has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Hayato Ohshima
Division of Anatomy and Cell Biology of the Hard Tissue, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences
4 shared publications Kae Matsuyama
Division of Anatomy, Department of Health Promotion, Kyushu Dental University, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, 803-8580, Japan
3 shared publications- Shinji Kataoka
Division of Anatomy, Department of Health Promotion, Kyushu Dental University, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, 803-8580, Japan
3 shared publications Takashi Toyono
Division of Anatomy, Department of Health Promotion, Kyushu Dental University, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, 803-8580, Japan
3 shared publicationsYuji Seta
Division of Anatomy, Department of Health Promotion, Kyushu Dental University, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, 803-8580, Japan
3 shared publications- Hiroko Ida-Yonemochi
Division of Anatomy and Cell Biology of the Hard Tissue, Department of Tissue Regeneration and Reconstruction, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
2 shared publications
Latest Publications
- 30 December 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100729
Lineage tracing of Twist2-expressing cells in mouse taste buds
- 30 December 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100729
Lineage tracing of Twist2-expressing cells in mouse taste buds
- Open Access
Wound-initiated hair regeneration by adhesive and shrinkable materials
Although there is a global demand for hair regrowth, particularly among middle-aged and older individuals, an effective hair growth technology has not yet been established 1 . Hair follicle neogenesis is restricted to the embryonic period, but hair regeneration accompanied by wound healing has been observed under some conditions 2–4 ; however, the underlying mechanisms are unclear. Herein, we demonstrated that creating a wound without dermal defects effectively induced postneonatal hair follicle neogenesis. Separating the epidermis from the dermis by topical application of adhesive and shrinkable materials to mouse skin promoted epidermal regeneration, followed by new hair follicle formation. Hair follicle regeneration, accompanied by the upregulation of related genes, can be induced in mice, including middle-aged and aged mice, regardless of species, sex, skin location, or age. The cycle of the regenerated hair eventually synchronized with that of the surrounding physiological hairs. Our new hair regeneration technique based on reproduction of epidermis–dermis interactions provides a novel means to treat hair loss, including androgenetic alopecia.
Open AccessWound-initiated hair regeneration by adhesive and shrinkable materials
Although there is a global demand for hair regrowth, particularly among middle-aged and older individuals, an effective hair growth technology has not yet been established 1 . Hair follicle neogenesis is restricted to the embryonic period, but hair regeneration accompanied by wound healing has been observed under some conditions 2–4 ; however, the underlying mechanisms are unclear. Herein, we demonstrated that creating a wound without dermal defects effectively induced postneonatal hair follicle neogenesis. Separating the epidermis from the dermis by topical application of adhesive and shrinkable materials to mouse skin promoted epidermal regeneration, followed by new hair follicle formation. Hair follicle regeneration, accompanied by the upregulation of related genes, can be induced in mice, including middle-aged and aged mice, regardless of species, sex, skin location, or age. The cycle of the regenerated hair eventually synchronized with that of the surrounding physiological hairs. Our new hair regeneration technique based on reproduction of epidermis–dermis interactions provides a novel means to treat hair loss, including androgenetic alopecia.
- Open Access
- 19 January 2024
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (1) , 90-97
Ser252Trp mutation in fibroblast growth factor receptor 2 promotes branching morphogenesis in mouse salivary glands
- 19 January 2024
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (1) , 90-97
Open AccessSer252Trp mutation in fibroblast growth factor receptor 2 promotes branching morphogenesis in mouse salivary glands
- 18 December 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 642, 75-82
Msx1 is essential for proper rostral tip formation of the mouse mandible
- 18 December 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 642, 75-82
Msx1 is essential for proper rostral tip formation of the mouse mandible
- Open Access
- 18 October 2022
- Published by Elsevier in Regenerative Therapy
- Vol. 21, 460-468
Role of osteopontin in the process of pulpal healing following tooth replantation in mice
- 18 October 2022
- Published by Elsevier in Regenerative Therapy
- Vol. 21, 460-468
Open AccessRole of osteopontin in the process of pulpal healing following tooth replantation in mice
- 1 December 2021
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 63 (4) , 420-428
Myogenic differentiation 1 and transcription factor 12 activate the gene expression of mouse taste receptor type 1 member 1
- 1 December 2021
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 63 (4) , 420-428
Myogenic differentiation 1 and transcription factor 12 activate the gene expression of mouse taste receptor type 1 member 1
- 14 October 2020
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 58 (6) , 697-706
Msx1 Heterozygosity in Mice Enhances Susceptibility to Phenytoin-Induced Hypoxic Stress Causing Cleft Palate
Objective: Cleft palate is among the most frequent congenital defects in humans. While gene–environment multifactorial threshold models have been proposed to explain this cleft palate formation, only a few experimental models have verified this theory. This study aimed to clarify whether gene–environment interaction can cause cleft palate through a combination of specific genetic and environmental factors. Methods: Msx1 heterozygosity in mice ( Msx1+/−) was selected as a genetic factor since human MSX1 gene mutations may cause nonsyndromic cleft palate. As an environmental factor, hypoxic stress was induced in pregnant mice by administration of the antiepileptic drug phenytoin, a known arrhythmia inducer, during palatal development from embryonic day (E) 11 to E14. Embryos were dissected at E13 for histological analysis or at E17 for recording of the palatal state. Results: Phenytoin administration downregulated cell proliferation in palatal processes in both wild-type and Msx1+/− embryos. Bone morphogenetic protein 4 ( Bmp4) expression was slightly downregulated in the anterior palatal process of Msx1+/− embryos. Although Msx1+/− embryos do not show cleft palate under normal conditions, phenytoin administration induced a significantly higher incidence of cleft palate in Msx1+/− embryos compared to wild-type littermates. Conclusion: Our data suggest that cleft palate may occur because of the additive effects of Bmp4 downregulation as a result of Msx1 heterozygosity and decreased cell proliferation upon hypoxic stress. Human carriers of MSX1 mutations may have to take more precautions during pregnancy to avoid exposure to environmental risks.
- 14 October 2020
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 58 (6) , 697-706
Msx1 Heterozygosity in Mice Enhances Susceptibility to Phenytoin-Induced Hypoxic Stress Causing Cleft Palate
Objective: Cleft palate is among the most frequent congenital defects in humans. While gene–environment multifactorial threshold models have been proposed to explain this cleft palate formation, only a few experimental models have verified this theory. This study aimed to clarify whether gene–environment interaction can cause cleft palate through a combination of specific genetic and environmental factors. Methods: Msx1 heterozygosity in mice ( Msx1+/−) was selected as a genetic factor since human MSX1 gene mutations may cause nonsyndromic cleft palate. As an environmental factor, hypoxic stress was induced in pregnant mice by administration of the antiepileptic drug phenytoin, a known arrhythmia inducer, during palatal development from embryonic day (E) 11 to E14. Embryos were dissected at E13 for histological analysis or at E17 for recording of the palatal state. Results: Phenytoin administration downregulated cell proliferation in palatal processes in both wild-type and Msx1+/− embryos. Bone morphogenetic protein 4 ( Bmp4) expression was slightly downregulated in the anterior palatal process of Msx1+/− embryos. Although Msx1+/− embryos do not show cleft palate under normal conditions, phenytoin administration induced a significantly higher incidence of cleft palate in Msx1+/− embryos compared to wild-type littermates. Conclusion: Our data suggest that cleft palate may occur because of the additive effects of Bmp4 downregulation as a result of Msx1 heterozygosity and decreased cell proliferation upon hypoxic stress. Human carriers of MSX1 mutations may have to take more precautions during pregnancy to avoid exposure to environmental risks.
- 1 January 2020
- Published by The Company of Biologists in Development
- Vol. 147 (21)
Msx1 deficiency interacts with hypoxia and induces a morphogenetic regulation during lip development
Nonsyndromic clefts of the lip and palate are common birth defects resulting from gene-gene and gene-environment interactions. MSX1 mutations have been linked to orofacial clefting and we show here that Msx1 deficiency causes a growth defect of the medial nasal process (Mnp) in mouse embryos. While this defect alone does not disrupt lip formation, Msx1-deficient embryos develop a cleft lip when the mother is transiently exposed to reduced oxygen levels or to Phenytoin, a drug known to cause embryonic hypoxia. In the absence of interacting environmental factors, the Mnp growth defect caused by Msx1-deficiency is modified by a Pax9-dependent “morphogenetic regulation”, which modulates Mnp shape, rescues lip formation and involves a localised abrogation of Bmp4-mediated repression of Pax9. Analyses of GWAS data revealed a genome-wide significant association of a Gene Ontology morphogenesis term (including assigned roles of MSX1, MSX2, PAX9, BMP4, GREM1) specifically for nonsyndromic cleft lip with cleft palate. Our data indicate that MSX1 mutations may increase the risk for cleft lip formation by interacting with an impaired morphogenetic regulation that adjusts Mnp shape, or through interactions that inhibit Mnp growth.
- 1 January 2020
- Published by The Company of Biologists in Development
- Vol. 147 (21)
Msx1 deficiency interacts with hypoxia and induces a morphogenetic regulation during lip development
Nonsyndromic clefts of the lip and palate are common birth defects resulting from gene-gene and gene-environment interactions. MSX1 mutations have been linked to orofacial clefting and we show here that Msx1 deficiency causes a growth defect of the medial nasal process (Mnp) in mouse embryos. While this defect alone does not disrupt lip formation, Msx1-deficient embryos develop a cleft lip when the mother is transiently exposed to reduced oxygen levels or to Phenytoin, a drug known to cause embryonic hypoxia. In the absence of interacting environmental factors, the Mnp growth defect caused by Msx1-deficiency is modified by a Pax9-dependent “morphogenetic regulation”, which modulates Mnp shape, rescues lip formation and involves a localised abrogation of Bmp4-mediated repression of Pax9. Analyses of GWAS data revealed a genome-wide significant association of a Gene Ontology morphogenesis term (including assigned roles of MSX1, MSX2, PAX9, BMP4, GREM1) specifically for nonsyndromic cleft lip with cleft palate. Our data indicate that MSX1 mutations may increase the risk for cleft lip formation by interacting with an impaired morphogenetic regulation that adjusts Mnp shape, or through interactions that inhibit Mnp growth.